Home / Inspections / 1258587

FDA Inspection 1258587 — Teva Pharmaceuticals USA, Inc

Teva Pharmaceuticals USA, Inc — FEI 3003092769

The FDA completed an inspection of Teva Pharmaceuticals USA, Inc on September 9, 2025 in Parsippany, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 9, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Parsippany, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Facility

Other inspections at this facility

  • 1219319 (VAI Fri Sep 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1160882 (NAI Thu Dec 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 703036 (VAI Thu Dec 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 645466 (VAI Mon Mar 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 600741 (VAI Fri Aug 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources